ITRM ITERUM THERAPEUTICS PLC Delisting Actions 8-K Filing 2024 - Nasdaq Delisting Notice Iterum Therapeutics plc has been notified by Nasdaq that it does not meet the minimum stockholders equity requirement for continued listing, but has requested a hearing to present a compliance plan and may receive an extension until March 31, 2025.Get access to all SEC 8-K filings of the ITERUM THERAPEUTICS PLC